Showing results (21-30 of 159) with videos related to
Sort By:
Pageof 16
Journal of the American Academy of Dermatology|March 12, 2005
Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trialCraig L Leonardi, Kim A Papp, Kenneth B Gordon, et al.Journal of Cutaneous Medicine and Surgery|May 16, 2006
Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part IDavid M Pariser, Kenneth B Gordon, Kim A Papp, et al.Seminars in Cutaneous Medicine and Surgery|October 1, 2014
Therapeutic development in psoriasisJeffrey M Sobell, Craig L LeonardiSeminars in Cutaneous Medicine and Surgery|December 2, 2015
Update on New and Emerging Therapies in the Management of PsoriasisKenneth B GordonSeminars in Cutaneous Medicine and Surgery|August 16, 2016
Translating the Science of PsoriasisKenneth B GordonJournal of Drugs in Dermatology : JDD|May 12, 2016
Reduction in C-Reactive-Protein Levels With Adalimumab Therapy in Patients With Moderate-to-Severe Hand and/or Foot PsoriasisCraig L Leonardi, Kristina Unnebrink, Wendell C ValdecantosDermatologic Clinics|November 22, 2014
Ten years on: the impact of biologics on the practice of dermatologyCraig L Leonardi, Ricardo Romiti, Paul W TebbeyDermatologic Clinics|September 29, 2004
From laboratory to clinic: rationale for biologic therapyStephanie Mehlis, Kenneth B GordonCore Evidence|August 10, 2010
Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasisEliana Krulig, Kenneth B GordonDermatologic Therapy|September 24, 2004
Adalimumab: efficacy and safety in psoriasis and rheumatoid arthritisToral Patel, Kenneth B GordonPageof 16